The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
Open accessAbstract
The fibroblast growth factor (FGF) 19 subfamily of ligands, FGF19, FGF21, and FGF23, function as hormones that regulate bile acid, fatty acid, glucose, and phosphate metabolism in target organs through activating FGF receptors (FGFR1-4). We demonstrated that Klotho and betaKlotho, homologous single-pass transmembrane proteins that bind to FGFRs, are required for metabolic activity of FGF23 and FGF21, respectively. Here we show that, like FGF21, FGF19 also requires betaKlotho. Both FGF19 and FGF21 can signal through FGFR1-3 bound by betaKlotho and increase glucose uptake in adipocytes expressing FGFR1. Additionally, both FGF19 and FGF21 bind to the betaKlotho-FGFR4 complex; however, only FGF19 signals efficiently through FGFR4. Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis. We conclude that the expression of betaKlotho, in combination with particular FGFR isoforms, determines the tissue-specific metabolic activities of FGF19 and FGF21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of KLB abolishes all effects of FGF21 in vitro and in vivo46,53–56.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 binding promotes the formation of a dimeric FGFR1c–KLB signalling complex, which activates the intracellular tyrosine kinase domains of FGFR1c and propagates signalling through phosphorylation by the kinase ERK46,53,58,59”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 elicits its biological effects by binding and activating a receptor complex composed of the co-receptor KLB and a traditional FGF receptor, fibroblast growth factor receptor 1c (FGFR1c)46,47.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“Interestingly, both FGF21 and another endocrine FGF, FGF15/19, share a requirement for KLB for signaling46,54, but what cross-talk, if any, exists between these signalling pathways in both physiological and pharmacological settings is unclear.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 signals to a receptor complex comprised of FGF receptor 1c (FGFR1c) and its co-receptor β-klotho (KLB) [[143], [144], [145], [146]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [143]
In the citing paper
“Importantly, since FGF receptors are ubiquitously expressed, endocrine FGFs require a coreceptor to provide signaling specificity, which for FGF21 and FGF19 is the coreceptor β-klotho (71, 99, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
In the citing paper
“FGF21 functions in target tissues that express the traditional FGF receptor FGFR1c and the obligate coreceptor β-klotho (2, 27, 71, 99, 124, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationReceptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 748
Okubo, H., Kushiyama, A., Nakatsu, Y., Yamamotoya, T., Matsunaga, Y., Fujishiro, M., Sakoda, H., Ohno, H., Yoneda, M., & Asano, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103064 · Cited by 18
Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance
Eder, K., Geßner, D. K., & Ringseis, R. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00621-y · Cited by 18
A Unique FGF23 with the Ability to Activate FGFR Signaling through Both αKlotho and βKlotho
Wu, X., Weiszmann, J., Ge, H., Baribault, H., Stevens, J. L., Hawkins, N., Vonderfecht, S. L., Gardner, J., Gupte, J., Sheng, J., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.02.027 · Cited by 17
Phelps, M., Stuelsatz, P., & Yablonka‐Reuveni, Z. (2016) · FEBS Journal · doi:10.1111/febs.13682 · Cited by 17
Hu, X., Xiong, Q., Xu, Y., Zhang, X., Pan, X., Ma, X., Bao, Y., & Jia, W. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.009 · Cited by 17
Endocrine Adiponectin‐FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury
You, M., Zhou, Z., Daniels, M. J., & Jogasuria, A. P. (2017) · Gene Expression · doi:10.3727/105221617x15093738210295 · Cited by 17
Fibroblast growth factor 23 and acute kidney injury
Neyra, J. A., Moe, O. W., & Hu, M. C. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-3006-1 · Cited by 17
Novel Sandwich Immunoassays for The Measurement of Total and Active Fgf21
Umberger, T. S., Sloan, J. H., Chen, J., Cheng, C., Siegel, R. W., Qian, Y., Troutt, J. S., & Konrad, R. J. (2014) · Bioanalysis · doi:10.4155/bio.14.241 · Cited by 16
FGF19 Contributes to Tumor Progression in Gastric Cancer by Promoting Migration and Invasion
Wang, S., Zhao, D., Tian, R., Shi, H., Chen, X., Liu, W., & Wei, L. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14537290676919 · Cited by 16
FGF-1 modulates pancreatic β-cell functions/metabolism: An in vitro study
Kolodziejski, P. A., Sassek, M., Bień, J., Leciejewska, N., Szczepankiewicz, D., Szczepaniak, B., Wojciechowska, M., Nogowski, L., Nowak, K. W., Strowski, M. Z., et al. (2020) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2020.113498 · Cited by 16
Identification and characterization of adipose surface epitopes
Onogi, Y., Khalil, A., & Ussar, S. (2020) · Biochemical Journal · doi:10.1042/bcj20190462 · Cited by 16
Kuro‐o, M. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.013 · Cited by 16
Self-citationZhang, J.-L., Li, H., Bai, N., Xu, Y., Song, Q., Zhang, L., Wu, G., Chen, S., Hou, X., Wang, C., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01018-5 · Cited by 16
Sakamoto, K., Kawata, Y., Masuda, Y., Umemoto, T., Ito, T., Asami, T., Takekawa, S., Ohtaki, T., & Inooka, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.009 · Cited by 15
Billeter, A. T., Scheurlen, K. M., Israel, B., Straub, B. K., Schirmacher, P., Kopf, S., Nawroth, P. P., & Müller-Stich, B. P. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005631 · Cited by 15
Sun, B., Yang, G., Yang, M., Liu, H., Boden, G. H., & Li, L. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.030 · Cited by 15
γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers
Trošt, N., Peña‐Llopis, S., Koirala, S., Stojan, J., Potts, P. R., Tacer, K. F., & Martínez, E. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6006 · Cited by 16
Murakami, T., Ueba, Y., Shinoto, Y., Koga, Y., Kaneda, D., Hatoko, T., Kato, T., Yonemitsu, S., Muro, S., & Oki, S. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.239.89 · Cited by 15
The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients
Rusu, C. C., Racasan, S., Kacsó, I. M., Moldovan, D. T., Potra, A. R., Tirinescu, D. C., Budurea, C., Orasan, R. A., Pațiu, I. M., Bondor, C. I., et al. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1474-x · Cited by 15
Exploring endocrine FGFs - structures, functions and biomedical applications
Phan, P. (2024) · International Journal of Biochemistry and Molecular Biology · doi:10.62347/palk2137 · Cited by 16
Isoform-specific inhibition of FGFR signaling achieved by a de-novo-designed mini-protein
Park, J. S., Choi, J., Cao, L., Mohanty, J., Suzuki, Y., Park, A., Baker, D. A., Schlessinger, J., & Lee, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111545 · Cited by 14
Amatya, R., Lee, D.-H., Min, K. A., & Shin, M. C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071963 · Cited by 13
Fan, X., Li, B., Zhang, F., Liu, M., Kwan, H. Y., Liu, Z., & Su, T. (2024) · Advanced Science · doi:10.1002/advs.202413525 · Cited by 14
Influence of Klotho Protein Levels in Obesity and Sarcopenia: A Systematic Review
Cobo, D. A., Estébanez, B., Arnáiz, E. G., García-Pérez, M. P., Rivera-Viloria, M., de la Maza, B. P., Galindo, D. E. B., Sastre, D. G., Ballesteros-Pomar, M. D., & Cuevas, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051915 · Cited by 14
Zapata, R. C., Singh, A., Pezeshki, A., & Chelikani, P. K. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.12.006 · Cited by 14
Gao, R., Kanasaki, K., Li, J., Kitada, M., Okazaki, T., & Koya, D. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12638 · Cited by 14
Kiluk, P., Baran, A. M., Kaminski, T. W., Maciaszek, M., & Flisiak, I. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122206 · Cited by 15
Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis
Li, S., Jia, H., Liu, Z., Wang, N., Guo, X., Cao, M., Fang, F., Yang, J., Li, J., He, Q., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-00906-2 · Cited by 14
Nakamura, K., Isoyama, N., Nakayama, Y., Hiroyoshi, T., Fujikawa, K., Miura, Y., Kurosu, H., Matsuyama, H., & Kuro‐o, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-17405-7 · Cited by 14
Self-citationGhosh, A., Chen, F., Banerjee, S., Xu, M., & Shneider, B. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00276.2013 · Cited by 14
Kobayashi, M., Nezu, Y., Tagawa, R., & Higami, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062854 · Cited by 14
Zhou, J., Ben, S., Tan, X., Xu, L., & Yao, X. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-798 · Cited by 13
Usui, N., Yoshida, M., Takayanagi, Y., Nasanbuyan, N., Inutsuka, A., Kurosu, H., Mizukami, H., Mori, Y., Kuro‐o, M., & Onaka, T. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13026 · Cited by 13
Self-citationTanycytes: bloodhounds of the metabolic brain
Rodriguez-Cortes, B., Gomez-Martínez, R., Spenle, R., Schwaninger, M., Nogueiras, R., Rasika, S., & Prévot, V. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.10.005 · Cited by 15
Zhou, Z., Zhang, H., Tao, Y., Zang, J., Zhao, J., Li, H., Wang, Y., Wang, T., Zhao, H., Wang, F., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102877 · Cited by 13
Update on Clinical Trials for Nonalcoholic Steatohepatitis.
Nathani, R. R., & Bansal, M. B. (2023) · PubMed Central · Cited by 13
Metabolic Syndrome in Youth: Current Insights and Novel Serum Biomarkers
Santoro, N., & Weiss, R. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.85 · Cited by 13
A variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolism.
Walters, J. R. F., & Appleby, R. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.03.38 · Cited by 13
Špolcová, A., Holubová, M., Mikulášková, B., Nagelová, V., Štofková, A., Lacinová, Z., Jur̀čovičová, J., Haluzı́k, M., Maletı́nská, L., & Železná, B. (2014) · Physiological Research · doi:10.33549/physiolres.932714 · Cited by 13
The central melanocortin system mediates the benefits of time-restricted feeding on energy balance
Sorrell, J. E., Yates, E., Rivir, M., Woods, S. C., Hogenesch, J. B., & Pérez–Tilve, D. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113132 · Cited by 13
Płatek, T., Polus, A., Góralska, J., Raźny, U., Dziewońska, A., Micek, A., Dembinska-Kiec, A., Solnica, B., & Malczewska-Malec, M. (2021) · Genes · doi:10.3390/genes12020307 · Cited by 12
Liu, X., Graham, Z., Harlow, L., Pan, J., Azulai, D., Bauman, W. A., Yarrow, J. F., & Cardozo, C. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.668984 · Cited by 12
Richter, M. M., Thomsen, M. N., Skytte, M. J., Kjeldsen, S. A. S., Samkani, A., Frystyk, J., Magkos, F., Holst, J. J., Madsbad, S., Krarup, T., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae008 · Cited by 13
Characterization of FGF21 Sites of Production and Signaling in Mice
Sullivan, A. I., Jensen-Cody, S. O., Claflin, K. E., Vorhies, K., Flippo, K. H., & Potthoff, M. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae120 · Cited by 11
Sun, X., Li, M., Li, A., Lan, X., Lei, C., Ma, W., Hua, L.-S., Wang, J., Hu, S., & Chen, H. (2013) · Livestock Science · doi:10.1016/j.livsci.2013.03.023 · Cited by 12
Domouzoglou, E. M., Vlahos, A. P., Cholevas, V., Papafaklis, M. I., Chaliasos, N., Siomou, E. C., Michalis, L. K., Tsatsoulis, A. A., & Naka, K. Κ. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040258.129 · Cited by 12
Increased plasma apoM levels impair triglyceride turnover in mice
Hajny, S., Borup, A., Elsøe, S., & Christoffersen, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158969 · Cited by 13
Non-alcoholic fatty liver disease and liver secretome
Khan, M. S., Lee, C.-H., & Kim, S. G. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01419-w · Cited by 13
Xu, P., Zhang, Y., Song, L., Khoso, M. H., Li, J., Jiang, X., He, J., Li, J., Ma, X., Ren, G., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.019 · Cited by 12
KLOTHO, FGF21 AND FGF23: NOVEL PATHWAYS TO MUSCULOSKELETAL HEALTH?
Bartali, B., Semba, R. D., & de Araújo, A. B. (2013) · The Journal of Frailty & Aging · doi:10.14283/jfa.2013.26 · Cited by 12
Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression
Lang, L., Shull, A. Y., & Teng, Y. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180319091731 · Cited by 12
Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease
Kondo, Y., Komaba, H., & Fukagawa, M. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1780918 · Cited by 12
Ghanem, M., Archer, G., Crestani, B., & Mailleux, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108669 · Cited by 12
Lin, Q., Zhang, J., Qi, J., Tong, J., Chen, S., Zhang, S., Liu, X., Lou, H., Lv, J., Lin, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202408688 · Cited by 11
Abulaban, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ahmed, E., Alruwaili, M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70067 · Cited by 11
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
Vachher, M., Bansal, S., Kumar, B., Yadav, S., Arora, T. K., Wali, N. M., & Burman, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30252 · Cited by 11
Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
Zangerolamo, L., Carvalho, M. U. W. B. D., Velloso, L. A., & Barbosa, H. C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176248 · Cited by 11
Rac-Dependent Signaling from Keratinocytes Promotes Differentiation of Intradermal White Adipocytes
Ueyama, T., Sakuma, M., Nakatsuji, M., Uebi, T., Hamada, T., Aiba, A., & Saito, N. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.06.140 · Cited by 11
Lin, H., Zhou, C., Hou, Y., Li, Q., Qiao, G., Wang, Y., Huang, Z., & Niu, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01515 · Cited by 11
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening
Kim, H. S., Dunshee, D. R., Yee, A., Tong, R. K., Kim, I., Farahi, F., Hongo, J.-A., Ernst, J. A., Sonoda, J., & Spiess, C. (2017) · Protein Engineering Design and Selection · doi:10.1093/protein/gzx034 · Cited by 11
Signaling Pathways in Liver Cancer
Wu, X., & Li, Y. (2012) · InTech eBooks · doi:10.5772/31381 · Cited by 11
FGFR4-driven plasticity in breast cancer progression and resistance to therapy
Braun, M., Piasecka, D., Sądej, R., & Romanska, H. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02658-y · Cited by 9
Zhang, J., Li, Y., Liu, Y., Ma, N., Qian, S., Chen, Y., Duan, Y., Xiang, X., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01267-9 · Cited by 10
Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog
Sass‐Ørum, K., Tagmose, T. M., Olsen, J., Sjölander, A., Wahlund, P., Han, D., Vegge, A., Reedtz‐Runge, S., Wang, Z., Gao, X., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00391 · Cited by 11
Jung, Y., Lee, K. W., Cho, J. H., Bae, D., Jeong, B.-G., Jung, Y.-J., Park, S., An, Y. J., Kim, K., Lee, G. S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-27717-x · Cited by 11
Zhu, S., Wu, Z., Wang, W., Wei, L., & Zhou, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02216-y · Cited by 10
Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone–Kidney–Gut Axis
Fujii, O., Tatsumi, S., Ogata, M., Arakaki, T., Sakaguchi, H., Nomura, K., Miyagawa, A., Ikuta, K., Hanazaki, A., Kaneko, I., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00359 · Cited by 10
The Pituitary Is a Candidate Organ That Modulates Circulating Klotho Levels
Sato, T., Komaba, H., Nagatani, T., Watanabe, T., Kishida, Y., & Fukagawa, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00223 · Cited by 10
Liu, H., Zheng, S., Hou, X., Liu, X., Du, K., Lv, X., Li, Y., Yang, F., Li, W., & Sui, J. (2020) · Cancer Science · doi:10.1111/cas.14353 · Cited by 9
Larson, K., Bundy, A. N., Lance, E. B., Darland, D. C., Casperson, S. L., & Roemmich, J. N. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108853 · Cited by 10
Zhao, Y., Liu, G., Kwok, S., Jones, B. R., Liu, J., Marchisin, D., Joyce, P., Peterson, J. E., & Shen, J. X. (2017) · Bioanalysis · doi:10.4155/bio-2017-0208 · Cited by 10
Sepa-Kishi, D. M., & Ceddia, R. B. (2018) · Adipocyte · doi:10.1080/21623945.2018.1504591 · Cited by 10
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
Sadowska, A., Poniedziałek‐Czajkowska, E., & Mierzyński, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417298 · Cited by 9
Li, S., Zou, W.-Y., Zhou, Y., Li, W., Liao, W., Li, T., & Zhang, Z.-M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1594091 · Cited by 9
Research progress on the role of FGF21 in insulin resistance
Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10
Zhang, Z., Li, X., Qiu, X., Yang, X., Lian, Z., Wei, X., Lu, D., & Xu, X. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200562 · Cited by 9
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Kwok, K. H. M., & Lam, K. S. L. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.145 · Cited by 9
Ito, N., Findlay, D. M., & Atkins, G. J. (2014) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-014-9155-8 · Cited by 9
Expression of FGF19 in human embryonic stem cells
Krejčı́, P., Bosakova, M. K., Kubíková, I., Trantı́rek, L., Kozubı́k, A., & Dvořák, P. (2013) · Stem Cells · doi:10.1002/stem.1493 · Cited by 9
Kim, J., Eskiocak, U., Stadler, G., Lou, Z., Kuro-o, M., Shay, J., & Wright, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267641 · Cited by 8
Self-citationHuang, Y., Zhang, Y., Yang, N., Qian, Z., Fang, Z., Zeng, L., Huang, Y., Li, H., Luo, M., Yan, J., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01463-y · Cited by 8
Zangerolamo, L., Carvalho, M. U. W. B. D., Solon, C., Sidarta-Oliveira, D., Soares, G. M., Marmentini, C., Boschero, A. C., Tseng, Y., Velloso, L. A., & Barbosa, H. C. L. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00488.2024 · Cited by 9
Usmanov, E. S., Chubarova, M. A., & Saidov, S. K. (2020) · Современные технологии в медицине · doi:10.17691/stm2020.12.5.11 · Cited by 8
Modh, D. H., Modi, S. J., Deokar, H. S., Yadav, S., & Kulkarni, V. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2053206 · Cited by 5
Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetes
Drexler, S., Cai, C., Hartmann, A.-L., Moch, D., Gaitantzi, H., Ney, T., Kraemer, M., Chu, Y., Zheng, Y., Rahbari, M., et al. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111934 · Cited by 8
Otani, Y., Nozaki, Y., Mizunoe, Y., Kobayashi, M., & Higami, Y. (2023) · Pathology International · doi:10.1111/pin.13371 · Cited by 8
Downregulation of klotho β is associated with invasive ductal carcinoma progression
Li, P., Zhao, M., Qi, X., Zhu, X., & Dai, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7110 · Cited by 8
Unraveling Endocrine FGF Signaling Complex to Combat Metabolic Diseases
Luo, Y., Lu, W., & Li, X. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.05.001 · Cited by 8
Targeting the Gut in Obesity: Signals from the Inner Surface
Petersen, N., Greiner, T. U., Torz, L., Bookout, A. L., Gerstenberg, M. K., Castorena, C. M., & Kuhre, R. E. (2022) · Metabolites · doi:10.3390/metabo12010039 · Cited by 8
Circulating factors that influence the central nervous system remyelination
Saitoh, S. S., Tanabe, S., & Muramatsu, R. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.12.001 · Cited by 8
Commentary: FGF21 Holds Promises for Treating Obesity-related Insulin Resistance and Hepatosteatosis
Alisi, A., Panera, N., & Nobili, V. (2013) · Endocrinology · doi:10.1210/en.2013-1828 · Cited by 8
Fibroblast growth factor-21 improves insulin action in nonlactating ewes
Lamb, C. L., Giesy, S. L., McGuckin, M. M., Perfield, J. W., Butterfield, A. M., Moniruzzaman, M., Haughey, N. J., McFadden, J. W., & Boisclair, Y. R. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00259.2021 · Cited by 7
Estradiol-dependent and independent effects of FGF21 in obese female mice
Jakovleva, T. V., Kazantseva, A. Y., Dubinina, A. D., Balybina, N. Y., Baranov, K. O., Makarova, E. N., & Бажан, Н. М. (2022) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-22-20 · Cited by 7
Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
Jia, M.-Q., Guan, C., Tao, J., & Zhou, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5042762 · Cited by 7
FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential
Xie, H., Glison, D. M. A., & Kim, R. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2017879 · Cited by 8
Sousa‐Coelho, A. L. D., Rodríguez‐Rodríguez, R., Softic, S., Jonker, J. W., & Relat, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1253675 · Cited by 7
The burn repair molecule? Evaluating FGF-21 in thermal injury – A systematic review
Niederegger, T., Schaschinger, T., Brandt, J., Knoedler, L., Knoedler, S. A., Palackic, A., Klimitz, F. J., Noll, D., Most, P., Ritterhoff, J., et al. (2025) · Burns · doi:10.1016/j.burns.2025.107785 · Cited by 6
Klotho in aging and diseases: molecular features, expressions, and functional implications
Marwein, M., Mukhim, L., Sah, P., Nongbri, D., & Suchiang, K. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05445-2 · Cited by 6
Xiong, C., Wang, Y., Li, Y., Yu, J., Wu, S., Wu, L., Zhang, B., Chen, Y., Gan, P., & Liao, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1203120 · Cited by 6
A primer on the pleiotropic endocrine fibroblast growth factor FGF19/FGF15
Bouju, A., Nusse, R., & Wu, P. V. (2024) · Differentiation · doi:10.1016/j.diff.2024.100816 · Cited by 7
Metadata
- Authors
- Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 282
- Issue
- 37
- Pages
- 26687-26695
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2496965
- OpenAlex
- W2048411348
- Cited by
- 748
- References
- 35
- Citations by year
- 2026: 37 · 2025: 24 · 2024: 33 · 2023: 31 · 2022: 55 · 2021: 46 · 2020: 44 · 2019: 48 · 2018: 52 · 2017: 47 · 2016: 38 · 2015: 40 · 2014: 43 · 2013: 43 · 2012: 51
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- Welch Foundation
- Ted Nash Long Life Foundation
- Eisai
- National Institutes of Health (1r01ag015326-01, DK067158)
- National Institute on Aging (R01AG19712, R01AG025326, R01 AG 15326, R01AG019712)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-067158, R01DK067158)
- National Institute of Dental and Craniofacial Research (R01DE13686, R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- β-Klotho, Klotho, FGF19, FGF21, fibroblast growth factor 23, fibroblast growth factor receptor, FGFR4, FGFR1, tissue-specific signaling, bile acid metabolism, CYP7A1, hepatocytes, metabolic hormones
- MeSH terms
- Fibroblast Growth Factor-23, Klotho Proteins, Animals, Cholesterol 7-alpha-Hydroxylase, Fibroblast Growth Factors, Humans, Membrane Proteins, Organ Specificity, Phosphorylation, Signal Transduction, Adipocytes, Protein Isoforms, Hepatocytes, 3T3-L1 Cells, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review